Skip to main content

Emergent BioSolutions Inc 10-Q for FY2022 Q2

Emergent BioSolutions Inc. (EBS)

10-Q 2022-08-02 For: 2022-06-30
View Original
Added on April 01, 2026

About this 10-Q

Emergent BioSolutions Inc filed this 10-Q on August 2, 2022, covering the quarter ended June 30, 2022 (FY2022 Q2).

Headline figures

Quarter ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$242.7M
down 38.9% from $397.5M a year earlier
Net loss
$56.4M
compared with net income of $4.6M a year earlier
Diluted EPS
-$1.13
compared with $0.09 a year earlier